Young Enough to Undergo Allogeneic Transplantation for Myelodysplastic Syndromes?: Considering the Results of the Medicare Coverage With Evidence Development Study

JAMA Oncol. 2020 Apr 1;6(4):493-494. doi: 10.1001/jamaoncol.2019.5135.

Authors

Georg-Nikolaus Franke¹, Anne Sophie Kubasch¹, Uwe Platzbecker¹

Affiliation

¹ Medical Department-Hematology and Cell Therapy, Medical Oncology, Hemostaseology, University of Leipzig Medical Center, Leipzig, Germany.

PMID: 31830213
DOI: 10.1001/jamaoncol.2019.5135

No abstract available

Publication types

Comment

MeSH terms

Aged
Humans
Medicare*
Myelodysplastic Syndromes*
Transplantation, Homologous
United States